Global InformationKerecis information
 | |
| Company type | Subsidiary |
|---|---|
| Founded | 2010 |
| Founder | Fertram Sigurjonsson |
| Headquarters | Ísafjörður , Iceland |
Area served | Iceland, Switzerland, and United States |
Key people | Fertram Sigurjonsson (CEO)[1][2] |
| Products |
|
| Revenue | 25,492,874 Euro (2021)  |
Number of employees | 196 (2021) |
| Subsidiaries | Phytoceuticals AG |
| Website | kerecis |
Kerecis is an Icelandic company that uses fish skins to treat wounds.[3][4] The decellularized skin of the Atlantic cod is used as a graft, which increases the elasticity, tensile strength, and compressibility of the wound.[5]
Kerecis has subsidiaries in Switzerland and the United States.[6] It is based in Ísafjörður, Iceland.[7][8]
In July 2023, Kerecis was sold to Danish company Coloplast for 1.2 billion USD.[9]
- ^ "Kerecis allt að 30 milljarða króna virði". Morgunblaðið.
- ^ "Kerecis bíður færis á yfirtökum". Fréttablaðið.
- ^ Hannan, Daniel (October 25, 2020). "Taking back control of fishing could be an enormous growth opportunity for Britain". The Daily Telegraph.
- ^ "Dans le poisson islandais, rien ne se perd, tout se transforme". Le Monde. October 16, 2021.
- ^ "Kerecis | Fish-Skin Technology |". May 20, 2021.
- ^ "Ólafur Ragnar kominn í stjórn Kerecis". Fréttablaðið.
- ^ "FDA Approves Kerecis' Implantable Fish-Skin Product". Iceland Monitor.
- ^ "Tekjur Kerecis þrefaldist og verði þrír milljarðar". Fréttablaðið.
- ^ "Ein stærstu kaup Íslandssögunnar". Morgunblaðið (in Icelandic). 7 July 2023. Retrieved 7 July 2023.